pI: 9.7417 |
Length (AA): 148 |
MW (Da): 15951 |
Paralog Number:
4
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Ortholog group members (OG5_131234)
Species | Accession | Gene Product |
---|---|---|
Brugia malayi | Bm1_30590 | Tyrosine-protein kinase abl-1 |
Caenorhabditis elegans | CELE_M79.1 | Protein ABL-1, isoform B |
Drosophila melanogaster | Dmel_CG4032 | Abl tyrosine kinase |
Echinococcus granulosus | EgrG_000904100 | tyrosine protein kinase ABL1 |
Echinococcus multilocularis | EmuJ_000526200 | tyrosine protein kinase Abl |
Echinococcus multilocularis | EmuJ_000904100 | tyrosine protein kinase ABL1 |
Homo sapiens | ENSG00000143322 | ABL proto-oncogene 2, non-receptor tyrosine kinase |
Homo sapiens | ENSG00000097007 | ABL proto-oncogene 1, non-receptor tyrosine kinase |
Loa Loa (eye worm) | LOAG_09621 | hypothetical protein |
Loa Loa (eye worm) | LOAG_05868 | TK/ABL protein kinase |
Mus musculus | ENSMUSG00000026596 | v-abl Abelson murine leukemia viral oncogene 2 (arg, Abelson-related gene) |
Mus musculus | ensembl-mmu:ENSMUSG00000026842 | c-abl oncogene 1, non-receptor tyrosine kinase |
Schistosoma japonicum | Sjp_0070320 | Tyrosine-protein kinase transforming protein Abl, putative |
Schistosoma japonicum | Sjp_0107860 | Proto-oncogene tyrosine-protein kinase ABL1, putative |
Schistosoma japonicum | Sjp_0040100 | Tyrosine-protein kinase transforming protein Abl, putative |
Schistosoma japonicum | Sjp_0315400 | expressed protein |
Schistosoma japonicum | Sjp_0218720 | expressed protein |
Schistosoma mansoni | Smp_128790 | tyrosine kinase |
Schmidtea mediterranea | mk4.000165.19 | |
Schmidtea mediterranea | mk4.001022.05 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Mus musculus | c-abl oncogene 1, non-receptor tyrosine kinase | Compounds | References |
Homo sapiens | ABL proto-oncogene 2, non-receptor tyrosine kinase | Compounds | References |
Abelson murine leukemia virus | Tyrosine-protein kinase V-ABL | Compounds | References |
Homo sapiens | ABL proto-oncogene 1, non-receptor tyrosine kinase | Compounds | References |